Sacral Neuromodulation and the Microbiome

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Urgency Urinary Incontinence
Interventions
DEVICE

InterStim Therapy

Sacral Neuromodulation, delivered by the InterStim® System, offers long-term control of bladder control and bowel control symptoms through modulation of the nerves that help control the pelvic floor and lower urinary tract.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

American Urogynecologic Society

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

University of Missouri-Columbia

OTHER

collaborator

University of North Carolina

OTHER

collaborator

University of Washington

OTHER

collaborator

Saint Francis Hospital and Medical Center

UNKNOWN

lead

Northwestern University

OTHER

NCT02833402 - Sacral Neuromodulation and the Microbiome | Biotech Hunter | Biotech Hunter